SEC Form 4 · accession 0001571049-15-009884
Cyclacel Pharmaceuticals, Inc. · CYCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul McBarron
Officer — E.V.P., Fin, C.F.O. & C.O.O. · Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130166
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF2,F1 | $0.589 | Dec 7, 2015 | A | 260,432 | A | — | Dec 7, 2025 | Common Stock | 260,432 | 260,432 | D |
Explanation of responses
- F1These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- F2These securities were granted to Mr. McBarron under the Issuer's 2015 Equity Incentive Plan as part of the Issuer's annual compensation review to executive officers.